Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Major impact of sampling methodology on gene expression in estrogen receptor positive breast cancer

ABSTRACT: Major impact of sampling methodology on gene expression in estrogen receptor positive breast cancer

PROVIDER: PRJNA415551 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Major impact of sampling methodology on gene expression in estrogen receptor positive breast cancer

Project description:To investigate the impact of sampling methodology on gene expression data from primary estrogen receptor positive (ER+) breast cancer biopsies. Analysis of global gene-expression measured in core-cut biopsies at baseline and surgery from patients randomised to receive either 2-week’s presurgical aromatase inhibitor (AI, n=157) or no presurgical treatment (n=56) revealed genes most markedly altered in the AI group (e.g. FOS, DUSP1, RGS1, FOSB) were equally altered in the no-treatment group; some widely investigated genes that were apparently unaffected in the AI group (e.g. MYC) were counter-altered in the Control group masking actual AI-dependent changes. In the absence of a Control group these artefactual changes would likely lead to the most affected genes being the erroneous focus of research. The findings are likely relevant to all archival collections of ER+ breast cancer.

2018-10-22 | GSE105777 | GEO

Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor-Positive Breast Cancer.

Project description:To investigate the impact of sampling methodology on gene expression data from primary estrogen receptor-positive (ER+) breast cancer biopsies, global gene expression was measured in core-cut biopsies at baseline and surgery from patients randomly assigned to receive either two weeks of presurgical aromatase inhibitor (AI; n = 157) or no presurgical treatment (n = 56). Those genes most markedly altered in the AI group (eg, FOS, DUSP1, RGS1, FOSB) were similarly altered in the no treatment group; some widely investigated genes that were apparently unaffected in the AI group (eg, MYC) were counter-altered in the control group, masking actual AI-dependent changes. In the absence of a control group, these artefactual changes would likely lead to the most affected genes being the erroneous focus of research. The findings are likely relevant to all archival collections of ER+ breast cancer.

| S-EPMC6649758 | biostudies-literature

Parus major major

Project description:Parus major major Genome sequencing

| PRJNA273693 | ENA

Comparison between Estrogen receptor positive and Estrogen receptor negative breast cancer samples

Project description:Comparison between Estrogen receptor positive and Estrogen receptor negative breast cancer samples Keywords: breast cancer type comparison

2008-09-17 | GSE10510 | GEO

Expression of oxysterol pathway genes in estrogen positive breast carcinomas-first phase

Project description:Metabolism of anticancer drugs markedly affects their antitumor effects. The major goal of our study was to investigate associations of gene expression of enzymes metabolizing taxanes and/or anthracyclines with therapy response and survival of breast carcinoma patients The present study investigated differences in transcript levels of key modulators of oxysterol signaling pathway, including oxysterol receptors, metabolic enzymes and transporters in the groups of estrogen receptor positive (ER+) breast carcinomas in comparison to estrogen receptor negative (ER-) ones, and to control non-tumor tissues.

2017-04-06 | GSE85207 | GEO

Comparison between Estrogen receptor positive and Estrogen receptor negative breast cancer samples

Project description:Comparison between Estrogen receptor positive and Estrogen receptor negative breast cancer samples Keywords: breast cancer type comparison 152 unique breast cancer tissue sample are included in the analysis. The total mRNA has been labeled with Cy5 and then hybridized on a two color arrays against the stratagen Human common reference that was previously labelled with Cy3.

2008-09-17 | E-GEOD-10510 | biostudies-arrayexpress

Assessment of RNA-seq Sample Preparation Methodology

Project description:Assessment of RNA-seq Sample Preparation Methodology

| PRJNA862601 | ENA

Assessment of RNA-seq Sample Preparation Methodology

Project description:Assessment of RNA-seq Sample Preparation Methodology

| PRJNA862603 | ENA

Endovascular Device for Endothelial Cell Sampling

Project description:We have developed an endovascular catheter-based device for sampling of the endothelium, intended for RNA-seq analysis. With an outer diameter of 0.23 mm it is capable of reaching peripheral vessels for endothelial sampling, and favourably compares to other approaches with stent retrievers or similar tools. Here, we have collected samples from liver and kidney vessels from swine and performed RNA-sequencing to validate the sample quality.

2022-08-21 | GSE197756 | GEO

Impact of Microglia Isolation and Culture Methodology on Transcriptional Profile and Function

Project description:Impact of Microglia Isolation and Culture Methodology on Transcriptional Profile and Function

| PRJNA1014108 | ENA